[13th European Congress of Medical Oncology. Prevention of uterine cancer, adjuvant treatment of early prostate cancer and the promises of nanotechnology].
Schaerling
E
E
Cedos international 23, rue Gourgas, 1205 Genève.
D000813:Anilides / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D019496:Cancer Vaccines; D016503:Drug Delivery Systems; D005260:Female; D006801:Humans; D008297:Male; D049329:Nanostructures; D009570:Nitriles; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D014105:Tosyl Compounds; D014594:Uterine Neoplasms / Q000517:prevention & control*
D000813:Anilides; D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D009570:Nitriles; D014105:Tosyl Compounds; C053541:bicalutamide